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Sport-related concussion remains one of the most complex
injuries presented to sports medicine professionals. Although
the injury has been recognized since ancient times, the
concussion-assessment process has seen significant advances
over the last 30 years. This review outlines the addition of
objective measures to the clinical evaluation of the concussed
athlete, beginning in the 1980s and continuing through the
modern age. International and domestic organizations now
describe standardized symptom reports, neurostatus and
neurocognitive-function evaluations, and postural-control mea-
sures as standards of medical care, a significant shift from a
short time ago. Despite this progression, much about the injury
remains unknown, including new clinical and research-based
assessment techniques and how the injury may influence the
athlete’s cognitive health over the long term.
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C
oncussions, the mildest form of traumatic brain
injury, have been cited as a ‘‘silent epidemic’’ by
the Centers for Disease Control and Prevention.1
Awareness of concussive injuries is not new and was noted
in the medical literature as far back as the 5th century BCE.
The Hippocratic Corpus noted that ‘‘commotion of the
brain’’ resulted in loss of speech, hearing, and sight.2 Injury
evaluation and management were not addressed in that
early document, and little changed in the understanding of
the injury through the Roman era.2 Indeed, injury
knowledge did not evolve until medieval times, when the
physician Lanfrancus established that concussive symptoms
were the result of a temporary loss of cerebral function that
resolved quickly. These symptoms were contrasted against
more serious injuries that resulted in physical damage to the
brain tissue.2 Further support for this concept came with the
advent of the microscope in the 17th century, when the idea
that concussion represented a clinical syndrome after insult
was first presented.2 Four hundred years later, the most
sophisticated medical microscopes—magnetic resonance
imaging and computed tomography imaging—have not
been able to demonstrate a structural change to the cerebral
tissue after concussion. Medical research has, however,
advanced in other areas and provided clinicians with
measures sensitive to postinjury clinical changes.
Various hypotheses on the mechanisms and underpin-
nings that result in the clinical signs and symptoms of
concussion have been proposed over the centuries, but our
current understanding is generally consistent with the
original theory.2 That is, the signs and symptoms of
concussion are the clinical manifestations resulting from a
change in the functional capacity of the cerebral tissue, and
injury resolution represents the natural return to homeosta-
sis of the impaired neurons.3 Recognizing that direct or
indirect forces to the brain may result in concussions,4
medical professionals are charged with rapidly identifying
the injured athlete to reduce the risk for further injury.
Before the 21st century, concussions were largely ignored
and were described in terms that diminished the injury
severity (eg, ‘‘clearing the cobwebs’’ or ‘‘getting your bell
rung’’). If an injury was suspected, the evaluation process
was largely subjective and involved asking the athlete
simple questions, such as ‘‘What is your name?’’, ‘‘Are you
OK?’’, or ‘‘How many fingers am I holding up?’’
Over the last 20 years, our understanding of concussion
mechanics, including cellular-level pathogenesis, and
injury assessment and management have increased dramat-
ically. Concussions during sport and recreation are now
thought to occur as often as 3.8 million times per year,5
resulting in up to 7 injuries per minute every day of the year
in the United States. Although each patient requires
individual management, 90% of concussed athletes recover
by day 7 after injury6 with little to no intervention;
evidence7 suggests that injured athletes who continue
playing and sustain additional head impacts experience
prolonged recoveries. To reduce this risk, most sports
medicine organizations4,8,9 now endorse the use of a
multifaceted examination to support the clinical evaluation
with an assessment battery that includes measures of
athlete-reported symptoms, neurocognitive status, and
balance. This information, which provides important
objective data to the clinician10,11 when making decisions,
was first used in 1982, when Barth et al12,13 launched the
seminal sport concussion work at the University of
Virginia: the Sports as a Laboratory Assessment Model
(SLAM). The intent of our literature review, therefore, is to
summarize the evolution of the modern objective concus-
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sion-assessment protocol relative to certified athletic
trainers (ATs) and other sports medicine professionals.
THE SYMPTOM EVALUATION
The signs and symptoms of concussion were the first
clinical aspects to be documented in uncovering the natural
history of the injury. The authors of the SLAM study12,14
described increases in headache, memory problems, and
dizziness after injury, with resolution over the next 10 days.
Since that time, ATs have used symptom checklists as the
primary evaluation tool for assessing the injury15; several
symptom checklists have been developed and placed into
clinical practice, with each intended for grading the
presence and severity of signs or symptoms. The Post-
Concussion Symptom Checklist was introduced in 1998
and proposed as a standardized assessment tool for the
evaluation of concussion-related postinjury symptoms.16
This checklist included 16 items similar to those used by
Barth et al.12 The International Conference on Concussion
in Sport (ICCS) group then suggested a standardized
concussion-symptom scale that contained 19 items.17 A
similar scale, the Graded Symptom Checklist, with 27
items, was endorsed by the National Athletic Trainers’
Association (NATA) shortly thereafter.18 Modifications to
the symptom list were made by the ICCS group in 2004,19
2008,20 and 20124; the most current version contains 22
items that are graded on a scale from zero (none) to 6
(severe).
Subtle differences exist among these scales, but the
symptoms of headache, dizziness, difficulty concentrating,
nausea, fatigue, trouble falling asleep, drowsiness, feeling
slowed down, and feeling in a fog are common to all. In
large studies21–23 of postconcussion symptoms, 83% of
concussed athletes reported headache, followed by dizzi-
ness (65%) and confusion (57%). These symptoms,
however, are often nonspecific and are commonly reported
among nonconcussed athletes.24 Some researchers25–27 have
therefore refined the symptom list to items that are most
relevant to concussion while maintaining comparable
psychometric properties. Pivotal to the advancement of
concussion clinical care was the recognition that symptoms
may be slow to develop in some concussed athletes.28
Clinical outcomes are not associated with loss of con-
sciousness,29 which occurs in less than 10% of all
patients.21
Evaluating and quantifying concussive signs and symp-
toms offer many advantages and have been shown to
identify approximately 90% of concussed athletes.11 In
spite of the broad implementation of these processes in
clinical care, athletes may be motivated to alter symptom
reports at baseline or postinjury for a number of reasons.
For example, anecdotal accounts suggest that some athletes
may inflate baseline symptom reports to mask elevated
postinjury scores. Others may not recognize concussive
signs and symptoms or intentionally not report them once
the injury occurs30–33 because of influence from teammates,
friends, coaches, or parents. Furthermore, some athletes
may be motivated to inflate symptom reports or continue
reporting symptoms despite injury resolution as a means to
leave a sport.
For these reasons and also because of the natural day-to-
day presence of symptoms commonly associated with
concussion,34,35 some degree of symptom reporting is not
unexpected. Clinicians, therefore, face the difficult task of
interpreting which symptoms are directly related to
concussion and which are related to other conditions. For
example, a headache in an athlete who has sustained a blow
to the head may be the result of a concussive injury but may
also originate from a neck injury,36 exercise, a migraine
headache, or simply wearing a helmet.37 These possibilities
are supported by the findings of a large investigation38 that
showed some evidence of concussionlike symptoms in
nonconcussed control populations. Others have demon-
strated that returning symptomatic athletes who are far
beyond the acute injury stage to exercise can reduce
symptoms,39,40 suggesting that long-term symptoms may
not be directly related to the concussion.41
Although symptom scales and checklists provide some
objectivity to the examination, they rely heavily on athlete
honesty and can be influenced by factors unrelated to
concussion. As such, symptom scales alone cannot
accurately identify all concussed athletes,10 nor can they
accurately identify injury recovery.42,43 This gap thus
requires more objective measures to complement and
extend the evaluative process.
THE NEUROCOGNITIVE ASSESSMENT
Neurocognitive testing developed as a way to evaluate
different domains of cognitive functioning (eg, memory,
concentration, or attention). Pencil-and-paper tests were
implemented largely to detect and evaluate gross cognitive
functioning, and the SLAM study14 was the first to apply
the tests to an athletic population. In that investigation,
2350 athletes from 10 universities completed the Paced
Auditory Serial Addition Test, the Digit Span Test, the
Trail Making Test, and a symptom evaluation. Each of the
195 athletes with a diagnosed concussion underwent
postinjury evaluations at fixed time points (24 hours and
days 5, 10, and 12); declines in cognitive functioning and
increased symptom reports were present immediately
postinjury and resolved over the next 10 days.14 This study
was the first to implement a baseline-postinjury assessment
in a sporting environment, which stands as the de facto
assessment model today. The only change has been a move
away from fixed assessment days to clinically derived
assessment points, including when the athlete is asymp-
tomatic and has been cleared to return to play after
performing a graded exercise protocol.8
Although remarkably innovative, the SLAM model was
also highly labor intensive, as the pencil-and-paper
neurocognitive assessment battery required substantial time
to administer on a one-on-one basis. Indeed, shortly after
the initial study findings were published, a similar model
was implemented by the Pittsburgh Steelers Organization
(with other professional teams following) but was met with
resistance, in part because of the testing duration. In
response, Mark Lovell, PhD, and his colleagues began
developing computer-based assessments that could be
administered in a manner that was rapid, systematic, and
repeatable.
Computer-based testing offered the promise of more
precise reaction-time measures, decreased practice effects
and administration time, and ease of administration.
Reaction times are recorded to the thousandth of a second,
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and computer programming automates the implementation
of alternate forms. Internal validity checks identify athletes
who may have intentionally performed poorly at baseline,44
although 10% may evade detection.45 Perhaps the key
features that resulted in the rapid adoption of computer-
based testing were the time and ease of administration.
Indeed, a complete pencil-and-paper neurocognitive eval-
uation of an athlete may have taken up to 4 hours, although
modified one-on-one batteries typically lasted 45 minutes.
Conversely, the time to complete computer-based tests can
be 20 to 30 minutes, and multiple athletes can be tested
concurrently under appropriate conditions.46 Injury sensi-
tivity improved from 23% to 44%10,11 on pencil-and-paper
tests to 63% to 82%10,47on the cognitive components of
computer-based tests, but concerns about reliability and
false-positive findings hampered recommendations for their
isolated use.48–51
Ultimately, given the time pressures of sports medicine,
practitioners were quick to adopt computer-based testing.
Indeed, in 2001, only 15% of ATs in all settings were using
any form of neurocognitive testing in the management of
patients with concussive injuries.52 The rates of pencil-and-
paper versus computer-based assessment were not provid-
ed, but the latter was just becoming available in the
marketplace at that time, suggesting that the former was
still the instrument of choice. Four years later, approxi-
mately 5% of surveyed ATs were using pencil-and-paper
tests, and an additional 15% reported using computer-based
assessments.53 Computer-based testing rose again to 33% in
2009.15 The current standard for the clinical management of
concussions by ATs is to include a neurocognitive
evaluation.8
Neurocognitive assessments have vastly improved the
concussion-assessment process, but their use is limited in
the athletic environment (eg, sideline). In recognition of
this limitation, the Standardized Assessment of Concussion
(SAC) was developed in 1997 as a neurostatus screening
tool for use in the field immediately postinjury.54 The SAC
outlined a standard clinical evaluation that included both
cognitive and physical assessments, and since its inception,
it has been widely disseminated and adopted for both
clinical4,8 and research38 use. Although the test has a high
level of sensitivity when administered immediately after
injury,11 its use beyond the 48-hour mark is less impressive.
Despite this, the SAC fills a large gap in the concussion-
management process left by neurocognitive testing and
provides the clinician with additional objective information
when administered immediately postinjury.
THE BALANCE ASSESSMENT
The addition of cognitive functioning to the clinical
assessment battery in the 1980s represented a movement
away from relying solely on subjective measures (ie,
symptoms) to the inclusion of objective measures that
supported the clinical examination. This movement contin-
ued with the addition of balance assessment in the next
decade. The earliest balance assessment used to evaluate
the functional abilities of the brain after injury was the
Romberg test.55 With the patient’s feet together and eyes
closed, the examiner subjectively evaluates irregular sway
patterns. However, the test results are highly subjective; the
examiner notes only if the sway pattern is normal or not
based on his or her clinical experience.
By implementing a modified version of the Romberg
test,56 Ingersoll and Armstrong57 were the first to identify
the importance of quantifying balance in relation to the
concussion-assessment protocol. They used force-plate
technology to track center-of-pressure movement and
objectively demonstrated increased anterior-posterior sway
during postinjury assessments of the concussed partici-
pants. Including multiple stable and unstable support
surfaces in a follow-up investigation demonstrated im-
paired balance up to 3 days postinjury.58 These findings
were replicated using advanced postural-control mea-
sures,59–61 and the authors59 concluded that the Romberg
test was insensitive to the balance deficits brought about by
concussive injuries.
Although these fundamental investigations forever
changed the concussion-assessment process, force-plate
technology was limited to research and hospital settings
that could afford this sophisticated equipment. The Balance
Error Scoring System (BESS) was therefore designed as a
low-cost objective measure of balance. The test imple-
mented components of the Shumway-Cook balance test56
(ie, firm and foam surfaces), modified the stances, and
added a procedure for objectively quantifying errors.62–64
The BESS error scores tracked closely with increased
center-of-pressure sway.65 As a result, the test was soon
included in large-scale clinical investigations of concus-
sion38,61 and became a standard of care for ATs.8,18 The
addition of an objective postural-control measure to the
concussion-assessment paradigm significantly strengthened
the evaluative process, with immediate postinjury (ie,
sideline) sensitivity increasing to 94% when combined with
a brief neurocognitive examination and symptom report.11
Similar to the SAC and all concussion assessments,
however, the sensitivity of the BESS declines rapidly in
the days postinjury11 as recovery is typically swift and
spontaneous.66
POSITION AND CONSENSUS STATEMENTS
The development of objective concussion-assessment
tools represents the integration of research into clinical
practice, with science verifying what can be applied in a
clinical setting. Ultimately, individual research projects
help to identify and validate assessment tools, but position
and consensus statements make these tools the standard for
clinical care. Several organizations have disseminated
statements over the years; none have been as influential
as those coming from the ICCS and the NATA.
In 2001, the first ICCS meeting was held in Vienna,
Austria. The document that emerged from that meeting had
a broad influence on concussion management, starting with
a new injury definition.17 The ‘‘complex pathophysiological
process brought about by biomechanical forces’’ reiterated
the well-established concept that the injury results from a
direct or indirect force to the head, the clinical signs and
symptoms represent a functional (not structural) change to
the cerebral tissue as demonstrated by normal imaging, and
the clinical impairments are typically short lived. New at
the time of publication, however, was a statement that loss
of consciousness was not an injury requirement and that
grading scales should be abandoned in guiding the return-
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to-play process. These changes ushered in the era of
individualized return-to-play management, with neurocog-
nitive testing (by computer or pencil and paper) emphasized
as the cornerstone technique for tracking recovery. Balance
testing was not included in the document, but the seminal
papers59,61 in this area had just been released. This was also
the first time a graduated return-to-play progression was
outlined, although the timing between steps and cognitive
rest was not addressed.
In 2004, the NATA published its first position statement
on the management of sport-related concussion.18 This
document called for the abandonment of colloquial terms
(eg, ‘‘ding,’’ ‘‘bell rung’’) and for baseline and postinjury
assessments of high-risk athletes that included measures of
symptoms, cognitive functioning, and postural control (ie,
BESS). Our understanding of the injury has since changed:
at the time, it was considered safe for concussed athletes to
return to play on the same day as injury if symptoms
resolved within 20 minutes and there was no loss of
consciousness or amnesia. Similar to the International Sport
Concussion Group, a progressive exercise protocol was
outlined for when the athlete became asymptomatic, but no
timeline was provided.
In that same year, ICCS met in Prague, Czech Republic,
to update its original statement. The revised document19
reversed the earlier version in presenting the concussion
grades of simple and complex. Simple concussions adhered
to a typical recovery curve (7–10 days) and required no
intervention or neurocognitive testing. Complex injuries
lasted longer than 10 days, presented with loss of
consciousness lasting more than 1 minute, or resulted in
prolonged impairment. The guidelines prescribed that
complex injuries be directly managed using neurocognitive
testing but did not indicate how the clinician was to
differentiate between simple and complex at the time of
injury. Neurocognitive testing remained the key feature of
the management process. However, the Standardized
Concussion Assessment Tool (SCAT) was introduced for
sideline use and included a neurologic screening tool, a
signs and symptoms evaluation, Maddocks questions, and
an abbreviated version of the SAC. Perhaps the most
important advances were that for the first time no same-day
return to play for concussed athletes was proposed, and the
concept of cognitive rest was introduced.
Four years later in Zurich, the ICCS met to update its
consensus recommendations.20 This version abandoned the
controversial simple-complex grading system and identified
the clinical examination as the key component of the
concussion diagnosis. The examination was to be supported
by neurocognitive testing, which was not to be used in
isolation but rather in conjunction with other assessment
measures. This was reflected in the SCAT2, which included
a modified version of the BESS (excluding foam-surface
testing), a graded symptom checklist, Maddocks questions,
and the complete SAC. Another key change was allowing a
same-day return-to-play recommendation for adult athletes
who showed complete symptom resolution.
The most recent ICCS meeting in 2012 resulted in few
substantial changes to the 2008 recommendations and
guidelines.4 The concussion diagnosis continued to be
based on the clinical examination but was supported by
other assessment modalities, and only the scoring, not the
content, of the SCAT changed. The total or composite
SCAT score was removed, allowing each component to be
scored independently and weighted equally. Additionally,
use of the full BESS (ie, inclusion of the foam conditions)
was recommended when possible to improve injury
sensitivity.4,67 Overall, the 2012 consensus group intro-
duced stricter guidelines regarding same-day return to play:
no athlete should be returned, regardless of age or recovery
status. Furthermore, the guidelines surrounding injury
management were clarified. That is, absolute physical and
cognitive rest was made less stringent; activities that did
not provoke symptoms were allowed. Also, a 24-hour
interval was instituted between return-to-play progression
steps, with most athletes taking approximately 1 week to
return to full participation once they become asymptomatic.
Most recently, the NATA updated its position statement on
concussion management in 2014 to reflect the scientific
advances that had occurred over the previous decade.8 The
new document placed the onus on ATs to educate their
athletes about the concussion-management process and to
document all aspects of injury management. Similar to the
2004 NATA statement,18 all athletes at high risk for injury
should undergo a baseline evaluation that includes a clinical
history with a symptom assessment, physical and neurologic
evaluation, and assessments for motor control and neurocog-
nitive function. In the event of an injury, all of these tools
should be implemented and used to support the clinical
examination, which stands as the criterion standard for injury
diagnosis. Once an injury is suspected or identified, no athlete
should be returned to play on the same day. Concussed
athletes should be removed from sport after injury, but
physical and mental exertion that does not exacerbate
symptoms is allowed. Unrestricted return to play, however,
is not permitted until the athlete resumes baseline levels of
performance and completes a 6-step exercise progression.
WHERE DO WE GO FROM HERE?
The science of diagnosing and managing concussion in
sport is still evolving, and although many questions have
been answered, much is still to be learned. In the last 15
years, published papers addressing concussions outnumber
those published in the entire century prior, and ATs are at
the forefront of much of this research. The most pressing
question for clinicians and researchers remains: ‘‘Is there a
biomarker that can identify and diagnose concussion and
indicate complete metabolic recovery?’’ Next, we need a
more definitive answer to ‘‘What are the long-term effects
of injury?’’
A number of research groups and private companies are
searching for a 100% accurate diagnostic marker that can
be deployed on the sideline within seconds of injury. Low-
cost vision-based tests that can be easily implemented on
the sideline or in a clinical setting have been investigated as
a diagnostic tool but with inconclusive results.68,69 Salivary
and serum samples have been the targets for many
investigators, but no single marker or combination has
been borne out.70 Conversely, advanced imaging tech-
niques, such as functional magnetic resonance imaging,
diffusion tensor imaging, magnetic resonance spectroscopy,
and event-related potentials, have shed light on many of the
brain’s inner workings. With respect to concussion, it is
reasonable to assume that brain-activation patterns after
concussion may remain altered despite normal performance
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on our best clinical-assessment tools.71,72 In addition,
metabolic changes in the brain may persist beyond the
time of clinical recovery.73–76 Measurements such as these
are costly and time consuming to obtain, yet they may be
the first step along the path to a diagnostic tool.
There is also considerable speculation that concussive
injuries, or even repetitive head impacts in the absence of
concussion, may propagate brain degeneration.77 Extreme
caution is warranted in interpreting these oft-publicized
results. These findings are limited by a lack of high-level
scientific designs, selection bias, lack of controls, and
failure to address other physiological and psychological
conditions that may have produced a similar outcome.
Additionally, numerous publications counter the specula-
tion of widespread long-term declines.78–86 Indeed, contact-
and collision-sport athletes live longer than the general
population; have no increased risk for dementia, Parkinson
disease, or amyotrophic lateral sclerosis87; and have a
suicide rate that is half the expected rate in the general
population.88 Despite these findings, science continues to
catch up with the misinformation communicated through
the media regarding possible relationships. These results do
not diminish our need to better understand the injury in the
long term and to emphasize that prospective trials
implementing a broad swathe of clinical assessments,
advanced imaging techniques, and genotyping will answer
these questions. Clinicians must therefore educate their
athletes as to what has been clearly demonstrated in the
literature and what remains to be proven.
CONCLUSIONS
No sports medicine topic is more polarizing than
concussion, and today’s standard of care supersedes where
we were just a decade or two ago. In the era of evidence-
based medicine, medical organizations are including
objective measures as part of their clinical care for patients
with concussive injuries. With the addition of each
validated measure, more and more of the guesswork is
being removed from the process, which is being quantified
in a clinically meaningful way. Measures of symptoms,
neurocognitive functioning, and postural control (ie,
balance) provide ample objective information that clini-
cians can successfully integrate into their decision making.
Injury management continues to be coordinated by the AT,
who now manages a multidisciplinary team of medical
professionals. Yet many questions persist about more
sophisticated injury diagnostic measures, postinjury reha-
bilitation, and the long-term effects of injury. In the
meantime, the responsible clinician must remain up to date
on this topic and balance between what is known and what
is reasonable and prudent for those patients in his or her
clinical care.
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